Michael Benatar is Walter Bradley Chair in ALS Research; Associate Professor of Neurology; and Chief of the Neuromuscular Division at the University of Miami. He completed his medical training at the University of Cape Town in South Africa and his residency and fellowship in neurology and clinical neurophysiology at Harvard Medical School. He obtained his doctoral degree in neuroscience from Oxford University in the United Kingdom and holds a Master of Science in Clinical Research from Emory University. He is the co-chair of the American Academy of Neurology (AAN) evidence-based medicine working group and an active member of the AAN Quality Standards Subcommittee. He serves on the editorial boards of the Cochrane Collaboration Neuromuscular Disease Group and Muscle and Nerve. His primary clinical and research interests include amyotrophic lateral sclerosis and myasthenia gravis. He has authored more than 40 peer-reviewed articles and several books about evidence-based neurology, including Analytic Neurology: Examining the Evidence for Clinical Practice and Neuromuscular Disease: Evidence and Analysis in Clinical Neurology. Dr. Benatar wrote for NEJM Journal Watch Neurology from 2010 through 2016.

Information about this editor was up to date at the time of his last affiliation with NEJM Journal Watch.